Abstract
High product titer is considered a strategic advantage of fed-batch over perfusion cultivationmode. The titer difference has been experimentally demonstrated and reported in the literature. However,the related theoretical aspects and strategies for optimization of perfusion processes with respect to theirfed-batch counterparts have not been thoroughly explored. The present paper introduces a unified frameworkfor comparison of fed-batch and perfusion cultures, and proposes directions for improvement of the latter.The comparison is based on the concept of “equivalent specific perfusion rate”, a variablethat conveniently bridges various cultivation modes. The analysis shows that development of economicallycompetitive perfusion processes for production of stable proteins depends on our ability to dramaticallyreduce the dilution rate while keeping high cell density, i.e., operating at low specific perfusion rates.Under these conditions, titer increases significantly, approaching the range of fed-batch titers. However,as dilution rate is decreased, a limit is reached below which performance declines due to poor growthand viability, specific productivity, or product instability. To overcome these limitations, a strategyreferred to as “push-to-low” optimization has been developed. This approach involves an iterativestepwise decrease of the specific perfusion rate, and is most suitable for production of stable proteinswhere increased residence time does not compromise apparent specific productivity or product quality. Thepush-to-low approach was successfully applied to the production of monoclonal antibody against tumor necrosisfactor (TNF). The experimental results followed closely the theoretical prediction, providing a multifoldincrease in titer. Despite the medium improvement, reduction of the specific growth rate along with increasedapoptosis was observed at low specific perfusion rates. This phenomenon could not be explained with limitationor inhibition by the known nutrients and metabolites. Even further improvement would be possible if thecause of apoptosis were understood.
In general, a strategic target in the optimization of perfusion processes should be the decreaseof the cell-specific perfusion rate to below 0.05 nL/cell/day, resulting in high, batch-like titers.The potential for high titer, combined with high volumetric productivity, stable performance over many months,and superior product/harvest quality, make perfusion processes an attractive alternative to fed-batch production,even in the case of stable proteins.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
Abbreviations
- CSPR :
-
Cell specific perfusion rate (nL/cell/day)
- D :
-
Dilution rate (fermentor volumes/day)
- OP :
-
Operating point
- OTR :
-
Oxygen transfer rate (mM/L/day)
- OUR :
-
Oxygen uptake rate (mM/L/day)
- QP :
-
Specific production rate (pg/cell/day)
- RT :
-
Residence time (h)
- SGR :
-
Specific growth rate (1/day)
- t :
-
Time
- V :
-
Fermentor volume (L)
- VP :
-
Volumetric productivity (mg/L/day)
- X :
-
Cell concentration in fermentor (cells/mL)
- X H :
-
Cell concentration in harvest (cells/mL)
References
Konstantinov K, Thrift J, Chuppa S, Matanguihan R, Sajan E, Tsai Y, Michaels J (1997) In: Naveh D (ed) Recent advances in fermentation technology (RAFT-2), San Diego, November 15–18, 1997
Cohen D, Mered M, Simmons R, Dadson A, Figueroa C, Rice C (1992) 9th international biotechnology symposium, Crystal City, Virginia, August 16–21, 1992
Konstantinov K (1996) Biotech Prog 52:271–289
Konstantinov K, Tsai Y, Moles D, Matanguihan R (1996) Biotech Prog 12:100–109
Werner R, Noe W (1998) Cytotechnology 26:81–82
Kadouri A, Speir R (1997) Cytotechnology 24:89–98
Al-Rubeai M, Emery A, Chalder S, Jan D (1992) Cytotechnology, p 9
Bierau H, Perani A, Al-Rubeai M, Emery AJ (1998) Biotechnology 62:195–207
Griffiths JJ (1992) Biotechnology 22:21–30
Griffiths J, Looby D, Racher A (1992) Cytotechnology 9:3–9
Heijnen J, van Scheltina A, Straathof AJ (1992) Biotechnology 22:3–20
Runstadler P, Ozturk S, Ray N (eds) (1992) An evaluation of hybridoma cell specific productivity: perfusion immobilized, continuous suspension, and batch suspension cultures. Kluwer Academic, Dordrecht
Werner R, Walz F, Noe W, Konard AJ (1992) Biotechnology 22:51–68
Hansen K, Kjalke M, Rasmussen P, Kongreslev L, Ezban M (1997) Cytotechnology 24:227–234
Teige M, Weidemann R, Kretzmer GJ (1994) Biotechnology 34:101–105
Adamson R (1994) Ann Hematol 68:9–14
Rozales C, Chuppa S, Matanguihan R, Michaels J, Taticek R, Thrift J, Konstantinov K, Naveh D (1997) 15th ESACT meeting, Tours, France, 1997
Brandt H, Muthing J, Peter J, Lehman J (1994) Cytotechnology 16:89–100
Buntemeyer H, Wallerius C, Lehman J (1992) Cytotechnology 9:59–67
Chaplen F (1998) Cytotechnology 26:173–183
Lee Y, Yap P, Teoh A (1994) Biotech Prog 45:18–26
Ronningh O, Schartum M, Winsnes A, Lindberg G (1991) Cytotechnology 7:15–24
Acknowledgments
The term “push-to-low” was first introduced by our colleague Kathleen Harris. We would like to thank the off-shift crew who supported the long-term perfusion experiments. The contribution of our colleagues from the Medium Production Group is also gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Editor information
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Konstantinov, K. et al. (2006). The “Push-to-Low” Approach for Optimization of High-Density Perfusion Cultures of Animal Cells. In: Hu, WS. (eds) Cell Culture Engineering. Advances in Biochemical Engineering/Biotechnology, vol 101. Springer, Berlin, Heidelberg. https://doi.org/10.1007/10_016
Download citation
DOI: https://doi.org/10.1007/10_016
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-34006-5
Online ISBN: 978-3-540-34007-2
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)